MAPS, Eight Capital And Integrated V.C. Backs Numinus $6M Offering
The TDR Three Takeaways:
Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate
Psychedelic therapy clinic provider Numinus Wellness (TSX:NUMI) (OTC: NUMIF) announced
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What’s Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.
Numinus Wellness Inc.’s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.
Mushroom Tea For Use In Psychedelic Research Developed By Numinus Wellness
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and evidence-based psychedeli
Hemp Company Offers Ketamine-Assisted Therapy To Employees As A Healthcare Benefit
Plant-based wellness product provider HempLucid is advancing medically supervised ketamine-assisted therapy (KAP) as an employee healthcare benefit.